Renaissance Capital logo

RYZB News

Here's what the top-performing IPOs of 2023 tell us about 2024

RayzeBio logo

Get ready for a bevy of biotech IPOs. The 30 IPOs that raised $100 million or more in 2023 currently average a strong 25% return from offer, thanks to solid first day gains (+14%) that have built in the aftermarket (+9%). ...read more

Pessimism over Fed policy and geopolitical tensions topple year's large IPOs; here are the deals that have weathered the recent turmoil

RayzeBio logo

After a strong rally through July, markets have treaded water for the past three months as investors grow pessimistic about the possibility of near-term rate cuts, against a backdrop of political gridlock in the US and a new war abroad. The year's sizable IPOs...read more

Updated: Renaissance Capital's 3Q 2023 US IPO Market Review

RayzeBio logo

Large Tech IPOs Stage a Comeback in a Volatile 3Q The third quarter of 2023 produced 30 IPOs that raised a combined $7.8 billion, more than the proceeds raised in the full-year 2022 despite no...read more

US IPO Weekly Recap: Arm trades up after raising nearly $5 billion in 2023’s largest IPO to date

ARM

Five IPOs raised a combined $5.4 billion this past week, led by the blockbuster IPO of Arm (ARM). Three issuers submitted initial filings. The largest IPO of 2023 so far, Arm priced at the top of the range to raise $4.9...read more